LMG Life Sciences Awards EMEA 2022: information and updates

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

LMG Life Sciences Awards EMEA 2022: information and updates

lmg-life-sciences-awards-for-dat-600x400-emea.png

Important information and updates for the LMG Life Sciences Awards 2022

We are excited to inform you that the preeminent industry recognition programme for legal work in the life sciences industry, LMG Life Sciences Awards, is returning for 2022.


As you may have seen, we have updated the title of the awards to be inclusive of firms not only in Europe but also throughout the Middle East and Africa. 



In our research cycle we will ask that you submit nominations for leading practitioners, firms, cases, and deals. 



We will be recognising the top work completed by private practice firms, as well as in-house counsel, from 2021. 



Register your interest today so you do not miss out! 


more from across site and SHARED ros bottom lb

More from across our site

The combined firm, which has a newly appointed IP partner in London, brings together more than 3,500 practitioners across 52 offices, with flagship hubs in Seattle, London, Sydney and New York
A host of SEP-rich law firms, both leading arguments and as intervenors, are set to feature in the UK Supreme Court’s third FRAND episode, though one claim has been settled
Law firms are investing in generative engine optimisation and boosting their online presence in the hope of gaining a new client base
A decision on a licensing rate payable by Warner Bros and Paramount, and a survey outlining UK businesses’ lack of IP preparation ahead of launching abroad, were among other major talking points
A fresh wave of deals highlights why investors favour IP firms and why independent outfits may soon have to rethink their strategy
King & Spalding has now hired 15 partners from Winston Taylor and legacy firm Winston & Strawn in offices spanning Texas, San Francisco, and Chicago
Firm says its work with a biotech client could signal a sea change in how - and when - law firms enter the drug development process
Evan Lazerowitz, attorney in Robinson + Cole’s bankruptcy and reorganisation group, offers key takeaways for IP interested parties in bankruptcy and insolvency proceedings
While the UK sees heavy IP rankings movement, Germany’s new tiered UPC table signals a shift from early adoption to market maturity
In an exclusive interview, Bernard Ledeboer reveals how a Consolid-backed group of firms wants to expand across Europe, invest in AI and centralise operations to compete at the top tier
Gift this article